JUL 14, 2019 11:23 AM PDT

Scratching a Chronic Itch

WRITTEN BY: Carmen Leitch

There are many potential reasons why skin might itch, but this annoying condition can significantly impact quality of life when it doesn’t go away. Scientists have had difficulty understanding what causes chronic itch, and while there are theories, there isn’t an effective treatment. New work reported in Science Translational Medicine may help change that.

Nerves that stimulate skin are grouped in structures next to the spinal cord. Here, nerves in such a structure -- called a dorsal root ganglion -- that are involved in detecting an itch are labeled green. Nerves involved in sensing pain, temperature and other stimuli are shown in magenta. / Credit: Hans Juergen Solinski, National Institute of Dental and Craniofacial Research

In previous work, National Institute of Dental and Craniofacial Research (NIDCR) researcher Mark Hoon, Ph.D., and colleagues identified a receptor called Npr1. It was found on nerve cells in mouse spinal cord neurons and binds to a protein that’s been linked to itch. When the Npr1 receptor is bound to the protein, it helps cause the itch sensation. Blocking Npr1 then became a strategy in the search for drugs that can control chronic itch.

to develop drugs from what they identify eventually discover a therapeutic that can block Npr1, and potentially relieve chronic itchiness, researchers at the National Center for Advancing Translational Sciences (NCATS) and the NIDCR used a rapid screening technique to assess 86,000 compounds.

Hoon collaborated with NCATS scientist James Inglese, Ph.D., and his team to screen the molecules. They developed a variety of tests in their effort, and along with robot helpers, they narrowed the pool of potential drugs to about 1,400 compounds. Next, they created a new set of assays to identify the best candidates. A subset of fifteen molecules was eventually shown to stop the Npr1 receptor from functioning in both human and mouse cells. Following up in a mouse model, the scientists found that by block ing Npr1, scratching was reduced.

The investigators are continuing to search for more drugs that can stop Npr1 from binding its target and causing itchiness, and want to eventually develop drugs from what they identify.

"This is a proof-of-concept study and an important application of what NCATS does," Inglese said. "We wanted to show that by pharmacologically blocking the target receptor, the approach could be successful in finding a drug to treat chronic itch. Because it can take a long time to develop an ideal compound, the rationale behind the approach needs to be well-vetted."

Learn more about chronic itch from the video above, and why scratching an itch can make it worse from the following video.

Sources: AAAS/Eurekalert! Via NIH/NCATS, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 25, 2019
Cell & Molecular Biology
AUG 25, 2019
Changing What we Think About the Transition to Multicellular Life
Time to rewrite the textbooks. A new study by University of Queensland researchers is calling old ideas about evolution into question....
AUG 25, 2019
Microbiology
AUG 25, 2019
Vulnerability in Famously Hard-to-Target Viruses is Identified
The cold virus is famously difficult to target with drugs because it can mutate rapidly....
AUG 25, 2019
Cancer
AUG 25, 2019
Self-Destructing Cancer: Study Stops Chain Reaction of Tumor Growth
A new study reveals that stopping one protein from functioning can cause some cancer cells to die from stress....
AUG 25, 2019
Health & Medicine
AUG 25, 2019
Are Eggshells the Future of Bone Repair?
A team of researchers from the University of Massachusetts Lowell has developed a technique to enhance the growth of new bones using eggshells. In a statem...
AUG 25, 2019
Microbiology
AUG 25, 2019
The Long Evolutionary History of Antibiotics and Resistance
The world is full of bacteria that have to share the world with myriad species, and often have to live in competition with other microbes....
AUG 25, 2019
Genetics & Genomics
AUG 25, 2019
Modified CRISPR Can Manipulate Gene Activity in Neurons
There are challenges to working with nerve cells in the lab, which can create research bottlenecks in the study of neurological disease....
Loading Comments...